How long can glioma patients live

How long can glioma patients live? This is the most urgent question that many patients and their families want to know. How long can glioma patients live depends on the cause of the disease and the treatment method. As long as the treatment method is appropriate, the patient still sees hope of defeating the cancer. Let's talk about how long glioma patients can live in detail.

How long can a patient with brain glioma live? The size of the tumor is not positively correlated with the patient's survival period. A large tumor does not necessarily mean a short survival period, and a reduced tumor does not necessarily mean a long survival period. The health of the body is closely related to the patient's survival period and quality of life.

How long can a patient with malignant glioma live? Among brain tumors, glioma has the highest incidence, accounting for about 40.49%, and the peak age of onset is 30-40 years old, or 10-20 years old. Glioma occurring in the cerebral hemisphere accounts for about 51.4% of all gliomas, with astrocytoma being the most common, followed by glioma and oligodendroglioma. The ventricular system is also a site where gliomas occur more frequently, accounting for 23.9% of the total number of gliomas, mainly vascular dysplasia, medulloblastoma, astrocytoma, and cerebellar glioma accounts for 13% of the total number of gliomas, mainly astrocytoma.

How long a patient can live with a brain tumor depends mainly on the treatment method and the patient's own physical condition, so patients should clearly cooperate with doctors for better treatment. Many experts have shown that combined treatment plays a big role in the cure of patients' conditions. The same is true for malignant gliomas.

Generally speaking, the median survival of low-grade mixed gliomas is about 6-7 years, and the 5-year and 10-year survival rates are 60% and 35%, respectively. The median survival of high-grade mixed gliomas is about 3-5 years, and the 5-year and 10-year survival rates are 55% and 30%, respectively.

The overall prognosis of ependymoma is related to the degree of tumor resection, the dose of postoperative radiotherapy, the site of tumor growth and the patient's age of onset. According to literature reports, the 5-year survival rate is 40%-80%. The 5-year progression-free survival rate is 25%-50%. After surgery + radiotherapy, the 5-year survival rate of low-grade ependymoma is 87%, and the 10-year survival rate is 79%. High-grade ependymoma is much worse, with a 5-year survival rate of only 27%. 80% have local recurrence within 5 years. 90% of patients with fourth ventricle tumors (grade II) survive for more than 10 years, the 10-year survival rate of lateral ventricle tumors is 60%, and the 10-year survival rate of third ventricle tumors is 35%. The average survival of patients under 10 years old is 2 years, and the average survival of patients over 15 years old is 4.3-6 years.

A brief survival analysis of the above-mentioned gliomas shows that there are many factors that determine survival time. Therefore, it is of little practical significance to take this issue too seriously. Active and scientific treatment is the basic condition for maximizing survival.